BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 17907177)

  • 1. PlA1/A2 polymorphism of the platelet glycoprotein receptor IIIA and risk of cranial ischemic complications in giant cell arteritis.
    Salvarani C; Casali B; Farnetti E; Pipitone N; Formisano D; Nicoli D; Macchioni P; Cimino L; Bajocchi G; Grazia Catanoso M; Restuccia G; Ghinoi A; Boiardi L
    Arthritis Rheum; 2007 Oct; 56(10):3502-8. PubMed ID: 17907177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-10 promoter polymorphisms in giant cell arteritis.
    Boiardi L; Casali B; Farnetti E; Pipitone N; Nicoli D; Macchioni P; Cimino L; Bajocchi G; Catanoso MG; Pattacini L; Salvarani C
    Arthritis Rheum; 2006 Dec; 54(12):4011-7. PubMed ID: 17133531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. -463 G/A myeloperoxidase promoter polymorphism in giant cell arteritis.
    Salvarani C; Casali B; Farnetti E; Pipitone N; Nicoli D; Macchioni PL; Cimino L; Bajocchi GL; Catanoso MG; Pattacini L; Ghinoi A; Restuccia G; Boiardi L
    Ann Rheum Dis; 2008 Apr; 67(4):485-8. PubMed ID: 17704068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial nitric oxide synthase gene polymorphisms in giant cell arteritis.
    Salvarani C; Casali B; Nicoli D; Farnetti E; Macchioni P; Catanoso MG; Chen Q; Bajocchi G; Boiardi L
    Arthritis Rheum; 2003 Nov; 48(11):3219-23. PubMed ID: 14613286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6 promoter polymorphism at position -174 in giant cell arteritis.
    Salvarani C; Casali B; Farnetti E; Pipitone N; Nicoli D; Macchioni P; Cimino L; Bajocchi G; Catanoso MG; Boiardi L
    J Rheumatol; 2005 Nov; 32(11):2173-7. PubMed ID: 16265697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intercellular adhesion molecule 1 gene polymorphisms in polymyalgia rheumatica/giant cell arteritis: association with disease risk and severity.
    Salvarani C; Casali B; Boiardi L; Ranzi A; Macchioni P; Nicoli D; Farnetti E; Brini M; Portioli I
    J Rheumatol; 2000 May; 27(5):1215-21. PubMed ID: 10813290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-reactive protein gene polymorphisms in biopsy-proven giant cell arteritis from Northwestern Spain.
    Palomino-Morales R; Vazquez-Rodriguez TR; Miranda-Filloy JA; Martin J; Gonzalez-Gay MA
    J Rheumatol; 2009 Feb; 36(2):341-6. PubMed ID: 19040303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A functional variant of vascular endothelial growth factor is associated with severe ischemic complications in giant cell arteritis.
    Rueda B; Lopez-Nevot MA; Lopez-Diaz MJ; Garcia-Porrua C; Martín J; Gonzalez-Gay MA
    J Rheumatol; 2005 Sep; 32(9):1737-41. PubMed ID: 16142870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor gene polymorphisms in giant cell arteritis.
    Boiardi L; Casali B; Nicoli D; Farnetti E; Chen Q; Macchioni P; Catanoso MG; Pulsatelli L; Meliconi R; Salvarani C
    J Rheumatol; 2003 Oct; 30(10):2160-4. PubMed ID: 14528511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of association between STAT4 gene polymorphism and biopsy-proven giant cell arteritis.
    Palomino-Morales R; Vazquez-Rodriguez TR; Morado IC; Castañeda S; Ortego-Centeno N; Miranda-Filloy JA; Lamas JR; Martin J; Gonzalez-Gay MA
    J Rheumatol; 2009 May; 36(5):1021-5. PubMed ID: 19332627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between toll-like receptor 4 gene polymorphism and biopsy-proven giant cell arteritis.
    Palomino-Morales R; Torres O; Vazquez-Rodriguez TR; Morado IC; Castañeda S; Callejas-Rubio JL; Miranda-Filloy JA; Fernandez-Gutierrez B; Martin J; Gonzalez-Gay MA
    J Rheumatol; 2009 Jul; 36(7):1501-6. PubMed ID: 19531762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of CD24 gene polymorphisms with susceptibility to biopsy-proven giant cell arteritis.
    Rueda B; Miranda-Filloy JA; Martin J; Gonzalez-Gay MA
    J Rheumatol; 2008 May; 35(5):850-4. PubMed ID: 18381780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet glycoprotein IIIa (platelet antigen 1/platelet antigen 2) polymorphism and 1-year outcome in patients with stable coronary artery disease.
    Addad F; Elalamy I; Chakroun T; Abderrazek F; Dridi Z; Hamdi S; Hassine M; Ben-Farhat M; Gerotziafas G; Hatmi M; Gamra H
    Blood Coagul Fibrinolysis; 2010 Oct; 21(7):674-8. PubMed ID: 20739877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of association of a functional -94ins/delATTG NFKB1 promoter polymorphism with susceptibility and clinical expression of biopsy-proven giant cell arteritis in northwest Spain.
    Martin J; Perez-Armengol C; Miranda-Filloy JA; Vilchez JR; Lopez-Nevot MA; Garcia-Porrua C; Gonzalez-Gay MA
    J Rheumatol; 2006 Feb; 33(2):285-8. PubMed ID: 16465659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of association between intercellular adhesion molecule-1 gene polymorphisms and giant cell arteritis.
    Amoli MM; Shelley E; Mattey DL; Garcia-Porrua C; Thomson W; Hajeer AH; Ollier WE; Gonzalez-Gay MA
    J Rheumatol; 2001 Jul; 28(7):1600-4. PubMed ID: 11469468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of association between IRF5 gene polymorphisms and biopsy-proven giant cell arteritis.
    Torres O; Palomino-Morales R; Vazquez-Rodriguez TR; Castañeda S; Morado IC; Miranda-Filloy JA; Valero F; Callejas-Rubio JL; Fernandez-Gutierrez B; Martin J; Gonzalez-Gay MA
    J Rheumatol; 2010 Jan; 37(1):136-40. PubMed ID: 19918036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Pl(A1/A2) polymorphism of glycoprotein IIIa and cerebrovascular events in hypertension: increased risk of ischemic stroke in high-risk patients.
    Lanni F; Santulli G; Izzo R; Rubattu S; Zanda B; Volpe M; Iaccarino G; Trimarco B
    J Hypertens; 2007 Mar; 25(3):551-6. PubMed ID: 17278970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycoprotein IIIA gene (PlA) polymorphism and aspirin resistance: is there any correlation?
    Papp E; Havasi V; Bene J; Komlosi K; Czopf L; Magyar E; Feher C; Feher G; Horvath B; Marton Z; Alexy T; Habon T; Szabo L; Toth K; Melegh B
    Ann Pharmacother; 2005 Jun; 39(6):1013-8. PubMed ID: 15840736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis.
    Salvarani C; Cimino L; Macchioni P; Consonni D; Cantini F; Bajocchi G; Pipitone N; Catanoso MG; Boiardi L
    Arthritis Rheum; 2005 Apr; 53(2):293-7. PubMed ID: 15818722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet and anticoagulant therapy in patients with giant cell arteritis.
    Lee MS; Smith SD; Galor A; Hoffman GS
    Arthritis Rheum; 2006 Oct; 54(10):3306-9. PubMed ID: 17009265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.